+987.9%
MRNA vs APD
+36.4%
+951.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | APD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.9% | +11.2% | +12.9% |
| 7D | +20.6% | +3.8% | +16.8% | +20.2% |
| 30D | +27.1% | +14.1% | +13.0% | +25.2% |
| 3M | +353.4% | +8.2% | +345.2% | +348.1% |
| 6M | +446.3% | +7.5% | +438.7% | +442.8% |
| YTD | +776.2% | +31.7% | +744.5% | +724.9% |
| 1Y | +987.9% | +35.1% | +952.8% | +884.1% |
| All | +987.9% | +36.4% | +951.6% | +884.1% |
Cumulative growth
Daily Returns
Daily percentage return beside APD.
Daily Out/Under-Performance
Portfolio return minus APD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × APD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded APD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling